Search

everythinglearnresearchcommunity

for

Search:↓

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

CD28 is a promising target for treating alopecia areata with belatacept.

CD28 is a promising target for treating alopecia areata with belatacept.

Alopecia areata involves immune system issues and specific cell types that disrupt hair growth, leading to hair loss.

Advances in RNA research and skin models offer hope for better skin healing without scarring.

The study identified key immune cell differences between mild and severe alopecia areata.

Belatacept may be a promising treatment for alopecia areata.

Researchers found four distinct fibroblast types in human skin, which could help in treating wounds and fibrotic diseases.

Blocking CXCL12 can reverse hair loss and fibrosis in androgenetic alopecia.

Single-cell encapsulation shows promise for medical use but faces production challenges.

Aged individuals heal wounds less effectively due to specific immune cell issues.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

Early intervention with JAK inhibitors may prevent alopecia areata progression.

Quercetin significantly helps hair growth by activating hair follicles and improving blood vessel formation around them.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

Aging reduces dermal sheath cells, affecting youthful skin appearance.

Alopecia areata is caused by an immune response, and targeting immune cells might help treat it.

Clonally expanded CD8+ T cells cause alopecia areata.

Different types of fibroblasts play specific roles in wound healing and cancer, which could help improve treatments.

Different types of inactive melanocyte stem cells exist with unique characteristics and potential to develop into other cells.

New insights into cell communication in psoriasis suggest innovative drug treatments.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

The research created a detailed map of skin cells, showing that certain cells in basal cell carcinoma may come from hair follicles and could help the cancer grow.

Psoriasis involves an imbalance between certain immune cells, and targeting these could help restore skin health.

Dermal sheath cells help heal wounds by showing both skin and connective tissue traits.

Machine learning and single-cell analysis improve understanding and treatment of wound healing.

Specific immune cells and pathways contribute to hair follicle inflammation and hair loss, suggesting potential treatments for lichen planopilaris.

Different scaffold patterns improve wound healing and immune response in mouse skin, with aligned patterns being particularly effective.

Immune cells in Hidradenitis suppurativa become more inflammatory and may be important for treatment targets.